Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Parrish

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
Genome Research|May 31, 2015
Analysis of dynamic changes in retinoid-induced transcription and epigenetic profiles of murine Hox clusters in ES cellsBony De Kumar, Mark E Parrish, Brian D Slaughter, et al.
Biopharmaceutics & Drug Disposition|December 23, 2020
Pharmacodynamics-based approach for efficacious human dose projection of BMS-986260, a small molecule transforming growth factor beta receptor 1 inhibitorKaren E Parrish, Jesse Swanson, Lihong Cheng, et al.
Molecular Cancer Therapeutics|October 7, 2015
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous SystemKaren E Parrish, Ling Cen, James Murray, et al.
The Journal of Infectious Diseases|June 9, 2001
Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretionsT V Ellerbrock, J L Lennox, K A Clancy, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 5, 2026
Multimodal Preclinical Assessment of Glucocorticoid-Induced Disruption of Bone Remodeling in Sprague-Dawley RatsAnik Tuladhar, Caitlyn Carter, Erin Vaughan, et al.
Molecular Cancer Therapeutics|September 27, 2017
Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in GlioblastomaSani H Kizilbash, Shiv K Gupta, Kenneth Chang, et al.
Journal of Medicinal Chemistry|October 27, 2021
Long-Acting Tumor-Activated Prodrug of a TGFβR InhibitorYong Zhang, Karen E Parrish, David R Tortolani, et al.
ACS Medicinal Chemistry Letters|March 18, 2021
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1Andrew P Degnan, Godwin K Kumi, Christopher W Allard, et al.
Molecular Cancer Therapeutics|July 5, 2018
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain BarrierMinjee Kim, Daniel J Ma, David Calligaris, et al.
Journal for Immunotherapy of Cancer|January 7, 2021
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitorDan You, Stephen Hillerman, Gregory Locke, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Genome Research|May 31, 2015
Analysis of dynamic changes in retinoid-induced transcription and epigenetic profiles of murine Hox clusters in ES cellsBony De Kumar, Mark E Parrish, Brian D Slaughter, et al.
Biopharmaceutics & Drug Disposition|December 23, 2020
Pharmacodynamics-based approach for efficacious human dose projection of BMS-986260, a small molecule transforming growth factor beta receptor 1 inhibitorKaren E Parrish, Jesse Swanson, Lihong Cheng, et al.
Molecular Cancer Therapeutics|October 7, 2015
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous SystemKaren E Parrish, Ling Cen, James Murray, et al.
The Journal of Infectious Diseases|June 9, 2001
Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretionsT V Ellerbrock, J L Lennox, K A Clancy, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 5, 2026
Multimodal Preclinical Assessment of Glucocorticoid-Induced Disruption of Bone Remodeling in Sprague-Dawley RatsAnik Tuladhar, Caitlyn Carter, Erin Vaughan, et al.
Molecular Cancer Therapeutics|September 27, 2017
Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in GlioblastomaSani H Kizilbash, Shiv K Gupta, Kenneth Chang, et al.
Journal of Medicinal Chemistry|October 27, 2021
Long-Acting Tumor-Activated Prodrug of a TGFβR InhibitorYong Zhang, Karen E Parrish, David R Tortolani, et al.
ACS Medicinal Chemistry Letters|March 18, 2021
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1Andrew P Degnan, Godwin K Kumi, Christopher W Allard, et al.
Molecular Cancer Therapeutics|July 5, 2018
Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain BarrierMinjee Kim, Daniel J Ma, David Calligaris, et al.
Journal for Immunotherapy of Cancer|January 7, 2021
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitorDan You, Stephen Hillerman, Gregory Locke, et al.
Pageof 17